𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phenotypic and molecular analysis of ph1-chromosome-positive acute lymphoblastic leukemia cell lines

✍ Scribed by T. Miyagi; J. Ohyashiki; K. Yamato; H. P. Koeffler; I. Miyoshi

Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
744 KB
Volume
53
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Role of granulocyte-macrophage colony-st
Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: Studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181)
✍ Z. Estrov; M. Talpaz; T. F. Zipf; H. M. Kantarjian; S. Ku; M. V. Ouspenskaia; C. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 970 KB

Philadelphia chromosome (Ph')-positive acute lymphoblastic leukemia (ALL) is a malignant disorder characterized by a poor prognosis. In recent years hematopoietic growth factors have been used to recruit myeloid leukemia blasts into the proliferative phase of the cell cycle and as supportive agents,

Philadelphia chromosome-positive acute l
Philadelphia chromosome-positive acute lymphoblastic leukemia after therapy for langerhans cell histiocytosis
✍ Tatsumi, Tetsuya; Shimazaki, Chihiro; Araki, Shin-Ichi; Sudo, Yoshikazu; Yamagat πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 2 views

To the Editor: Schwachman's syndrome, a familial disease transmitted as an autosomal-recessive trait, is characterized by moderate chronic neutropenia, marked marrow hypocellularity, occasional thrombocytopenia and anemia, metaphyseal dysostosis of tubular bones, pancreatic fatty infiltration, and a

Imatinib compared with chemotherapy as f
Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)
✍ Oliver G. Ottmann; Barbara Wassmann; Heike Pfeifer; Aristoteles Giagounidis; Mat πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 173 KB

## Abstract ## BACKGROUND Elderly patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph+ALL) have a poor prognosis, with a low complete remission (CR) rate, high induction mortality, and short remission duration. Imatinib (IM) has a favorable toxicity profile but limited